← Back to Search

Mobile Mental Health Platform for College Students' Mental Health (iAIM EDU Trial)

N/A
Waitlist Available
Led By Denise Wilfley, PhD
Research Sponsored by Washington University School of Medicine
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6 weeks, 6 months, and 2 years
Awards & highlights

iAIM EDU Trial Summary

This trial aims to test the effectiveness of a mobile mental health platform for detecting and engaging college students in services for anxiety, depression, and eating disorders.

Who is the study for?
This trial is for college students over 18 who are not currently in mental health treatment but screen high risk or clinical/subclinical for anxiety, depression, and eating disorders (except anorexia nervosa). Participants must own a smartphone to access the mobile intervention platform.Check my eligibility
What is being tested?
The study tests a mobile mental health platform against usual care referrals. It aims to engage students with anxiety, depression, or eating disorders in tailored services through population-level screening and evidence-based online programs.See study design
What are the potential side effects?
While specific side effects are not detailed for this type of intervention, users may experience discomfort or emotional distress when engaging with mental health content that reflects their personal challenges.

iAIM EDU Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6 weeks, 6 months, and 2 years
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6 weeks, 6 months, and 2 years for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Effectiveness of the mobile mental health platform, compared to usual care, in changing the number of individuals with mental health disorders.
Secondary outcome measures
Effectiveness of the mobile mental health platform, compared to usual care, in changing disorder-specific symptoms.
Effectiveness of the mobile mental health platform, compared to usual care, in changing quality of life and functioning.
Number of Participants who receive treatment on the mobile mental health platformed compared to number of participants who receive treatment in the control group.
Other outcome measures
Anxiety
Mental Depression
Examine if the mobile intervention changes cognitive-behavioral therapy (CBT) skills and if changes in CBT skills are associated with clinical benefit.
+3 more

iAIM EDU Trial Design

2Treatment groups
Experimental Treatment
Active Control
Group I: Mobile Coached InterventionExperimental Treatment1 Intervention
This group will receive access to the mobile intervention for 6 months. They will be assigned to the primary program (i.e., anxiety, depression, or eating disorders) they screen positive for. If a person screens positive for more than one disorder, they will be given the choice of which program they want to start with. They will also be provided preventive interventions for anxiety, depressive, or eating of disorders they may not have but be at risk for. After two weeks in the program, the coach will assign the components presumed to be essential to intervention effects for comorbid disorder(s) and risk factors.
Group II: Referral to Counseling CenterActive Control1 Intervention
This group will receive information about how to make an appointment at their counseling center and will be encouraged to do so.

Find a Location

Who is running the clinical trial?

National Institute of Mental Health (NIMH)NIH
2,783 Previous Clinical Trials
2,682,893 Total Patients Enrolled
666 Trials studying Depression
251,434 Patients Enrolled for Depression
Penn State UniversityOTHER
355 Previous Clinical Trials
119,501 Total Patients Enrolled
14 Trials studying Depression
1,884 Patients Enrolled for Depression
Washington University School of MedicineLead Sponsor
1,931 Previous Clinical Trials
2,293,453 Total Patients Enrolled
69 Trials studying Depression
23,379 Patients Enrolled for Depression

Media Library

SilverCloud Health Intervention Clinical Trial Eligibility Overview. Trial Name: NCT04162847 — N/A
Depression Research Study Groups: Referral to Counseling Center, Mobile Coached Intervention
Depression Clinical Trial 2023: SilverCloud Health Intervention Highlights & Side Effects. Trial Name: NCT04162847 — N/A
SilverCloud Health Intervention 2023 Treatment Timeline for Medical Study. Trial Name: NCT04162847 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there plentiful centers in Canada administering this trial?

"This study is currently recruiting from 4 sites, such as Palo Alto University in Palo Alto, Washington University School of Medicine located in Saint Louis, and Pennsylvania State University based in State College."

Answered by AI

Is enrollment for this experiment available to participants at the present time?

"According to information on clinicaltrials.gov, this investigation is not presently recruiting for participants; it was initially posted in October 2019 and last updated in July 2022. However, there are still 2183 other trials currently welcoming patients at the present moment."

Answered by AI

Who else is applying?

What state do they live in?
Wisconsin
Pennsylvania
Maryland
How old are they?
18 - 65
What site did they apply to?
Pennsylvania State University
What portion of applicants met pre-screening criteria?
Met criteria
Did not meet criteria
~1137 spots leftby Apr 2025